Pre-emptive therapy with azoles in lung transplant patients

European Respiratory Journal

Volumn 13, Issue 1, 1999, Pages 180-186

  Hamacher, J ^a   Spiliopoulos, A ^a   Kurt, A M ^a   Nicod, L P ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Fluconazole; Fungal infection; Itraconazole; Lung transplantation; Prophylaxis

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHITIS; BRONCHOSCOPY; CANDIDA ALBICANS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FUNGUS CULTURE; HUMAN; LUNG MYCOSIS; LUNG TRANSPLANTATION; MALE; MYCELIUM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD;

ADULT; ANTIFUNGAL AGENTS; CHILD; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032990184     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13a33.x     Document Type: Article

References (35)

1. Maurer JP, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992; 101: 1056-1059.
2. Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infections complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 1993; 153: 2010-2016.
3. Hibberd PL, Rubin RH, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19 Suppl. 1: S33-S40.
4. Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine 1996; 75: 142-156.
5. Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60: 580-584.
6. Paradis IL, Williams P. Infection after lung transplantation. Semin Respir Infect 1993; 8; 207-215.
7. Chaparro C, Maurer JR. Chamberlain D, et al. Causes of death in lung transplant recipients. J Heart Lung Transplant 1994; 13: 758-766.
8. Paradowski LJ. Saprophytic fungal infections and lung transplantation - revisited. J Heart Lung Transplant 1997; 16: 524-531.
9. Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant 1995; 14: 883-890.
10. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144: 552-556.
11. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11: 291-308.
12. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677-688.
13. Laghi F, Yeldandi V, McCabe M, Garrity ERJ. Common infections complicating lung transplantation. N Engl J Med 1993; 90: 313-319.
14. Shennib H, Noirclerc M, Ernst P, et al. Double-lung transplantation for cystic fibrosis. Ann Thorac Surg 1992; 54: 27-32.
15. Reichenspurner H, Gamberg P, Nitschke M, et al. Significant reduction in the number of fungal infections after lung, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transpl Proc 1997; 29: 627-628.
16. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
17. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation. A prospective, randomized, double blind study. J Infect Dis 1995; 171: 1545-1552.
18. Sobh M, El-Agroudy A, Moustafa F, Harras F, El-Bedewy M, Ghoneim M. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study. Am J Nephrol 1995; 15: 493-499.
19. Warnock DW. Fungal complications of transplantation: diagnosis, treatment and prevention. J Antimicrob Chemotherapy 1995; 36 (Suppl. B): 73-90.
20. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994; 149: 1601-1607.
21. Patterson TF, Peters J, Levine SM, et al. Systemic availability of itraconazole in lung transplantation. Antimicrob Agents Chemother 1996; 40: 2217-2220.
22. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263-272.
23. Working Party of the British Society for Antimicrobial Chemotherapy. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemotherapy 1993; 32: 5-21.
24. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155: 789-818.
25. Baselski VS, Robinson MK, Pifer LW, Woods DR. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using Celifluor staining. J Clin Microbiol 1990; 28: 393-394.
26. Larone DH. Medically Important Fungi. A Guide to Identification. Washington DC, American Society for Microbiology, 1995; pp. 227-228.
27. Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis 1987; 9 (Suppl. 1): S94-S99.
28. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of clinical significance. Drug Safety 1998; 18: 83-97.
29. Keogh A, Spratt P, McCosker C, Macdonald P, Mundy J, Kaan A. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 1995; 333: 628-633.
30. Tanoue LT. Lung transplantation. Lung 1992; 170: 187-200.
31. Kawai A, Paradis IL, Keenan RJ, et al. Lung transplantation at the University of Pittsburgh: 1982-1994. Clin Transpl 1994; 111-120.
32. Biggs VJ, Dummer S, Holsinger FC, Loyd JE, Christman BW, Frist WH. Successful treatment of invasive bronchial aspergillosis after single-lung transplantation. Clin Infect Dis 1994; 18: 123-124.
33. Chaparro C, Kesten S. Infections in lung transplant recipients. Clin Chest Med 1997; 18: 339-351.
34. Wagner JA, Ross H, Hunt S, et al. Prophylactic gancyclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. Transplantation 1995; 60: 1473-1477.
35. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-1368.